M F Cantwell1, N J Binkin. 1. Division of Tuberculosis Elimination, Centers for Disease Control and Prevention, Atlanta, GA, USA.
Abstract
BACKGROUND: The effect of the human immunodeficiency virus (HIV) epidemic on tuberculosis (TB) has been evaluated for certain countries in sub-Saharan Africa. However, no multi-country comparisons have been performed of the magnitude of the changes in TB case rates and the roles of the HIV epidemic and national TB control program (NTP) quality in these changes. METHODS: We examined trends in TB case rates after 1985 for 20 sub-Saharan African countries, and also from 1975-1984 for 10 of these countries (core countries). Average annual changes in TB case rates after 1985 were stratified by 1992 urban low-risk HIV seroprevalence and by NTP quality, as determined by a survey of international TB experts. RESULTS: Case rates in the core countries decreased by an average of -1.6% per year prior to 1985, but increased by an average of +7.0% per year after 1985 (+7.7% per year after 1985 in all 20 countries). Average annual case rates after 1985 increased approximately twice as fast in countries with high vs low or intermediate HIV seroprevalence ratings. In both the core countries and all 20 countries, the average annual rate of rise in case rates after 1985 decreased as NTP quality rating increased. This relationship persisted even after stratification by HIV seroprevalence rating. CONCLUSIONS: TB case rates have increased in sub-Saharan Africa since 1985. These increases were relatively greater as HIV seroprevalence increased, and relatively lower as NTP quality increased. Improving NTP quality is essential to mitigate the resurgence of TB in the HIV era.
BACKGROUND: The effect of the human immunodeficiency virus (HIV) epidemic on tuberculosis (TB) has been evaluated for certain countries in sub-Saharan Africa. However, no multi-country comparisons have been performed of the magnitude of the changes in TB case rates and the roles of the HIV epidemic and national TB control program (NTP) quality in these changes. METHODS: We examined trends in TB case rates after 1985 for 20 sub-Saharan African countries, and also from 1975-1984 for 10 of these countries (core countries). Average annual changes in TB case rates after 1985 were stratified by 1992 urban low-risk HIV seroprevalence and by NTP quality, as determined by a survey of international TB experts. RESULTS: Case rates in the core countries decreased by an average of -1.6% per year prior to 1985, but increased by an average of +7.0% per year after 1985 (+7.7% per year after 1985 in all 20 countries). Average annual case rates after 1985 increased approximately twice as fast in countries with high vs low or intermediate HIV seroprevalence ratings. In both the core countries and all 20 countries, the average annual rate of rise in case rates after 1985 decreased as NTP quality rating increased. This relationship persisted even after stratification by HIV seroprevalence rating. CONCLUSIONS: TB case rates have increased in sub-Saharan Africa since 1985. These increases were relatively greater as HIV seroprevalence increased, and relatively lower as NTP quality increased. Improving NTP quality is essential to mitigate the resurgence of TB in the HIV era.
Entities:
Keywords:
Africa; Africa South Of The Sahara; Comparative Studies; Cross-cultural Comparisons; Developing Countries; Diseases; Epidemics; Health Services Evaluation; Hiv Infections--prevention and control; Incidence; Infections; Measurement; Organization And Administration; Prevalence; Program Evaluation; Programs; Quality Of Health Care; Research Methodology; Research Report; Studies; Tuberculosis--prevention and control; Viral Diseases
Authors: J A Odhiambo; M W Borgdorff; F M Kiambih; D K Kibuga; D O Kwamanga; L Ng'ang'a; R Agwanda; N A Kalisvaart; O Misljenovic; N J Nagelkerke; M Bosman Journal: Am J Public Health Date: 1999-07 Impact factor: 9.308
Authors: Michael Siev; Douglas Wilson; Supreet Kainth; Victoria O Kasprowicz; Catherine M Feintuch; Elizabeth R Jenny-Avital; Jacqueline M Achkar Journal: Clin Vaccine Immunol Date: 2014-03-26
Authors: Gibson S Kibiki; Bert Mulder; Wil M V Dolmans; Jessica L de Beer; Martin Boeree; Noel Sam; Dick van Soolingen; Christophe Sola; Adri G M van der Zanden Journal: BMC Microbiol Date: 2007-05-31 Impact factor: 3.605